UK: Weetabix names Kimberly-Clark's Turrell as CEO
By Sam Webb | 1 September 2011
 |
Weetabix has appointed a new CEO |
UK cereal manufacturer Weetabix today (1 September) announced the appointment of Giles Turrell as CEO.
Turrell, who will take on the role next month, replaces Ken Wood, who is retiring after seven years at the helm of the company, which is owned by private-equity firm Lion Capital.
He will join Weetabix from paper goods company Kimberly-Clark, where he is president of its European consumer business.
He has served in a number of senior marketing and general management roles across different categories, initially with GlaxoSmithKline and, since 1997, with Kimberley-Clark.
Turrell said: "Weetabix is a robust and innovative business with a great portfolio of brands in a dynamic category. I am looking forward to working with the Weetabix team enormously."
Wood added: "I'd like to record my thanks for all the help, friendship and support that I've enjoyed. I am happy that I leave the business both in good shape and in good hands."
Sectors: Cereal
Companies: Weetabix
View next/previous articles
1 Sep 2011 -
1 Sep 2011 -
Currently reading -
UK: Weetabix names Kimberly-Clark's Turrell as CEO
Related research
Bakery and Cereals Market in Turkey - Product Launch Almanac 2010
Datamonitor’s Bakery and Cereals market in Turkey – Product Launch Almanac 2010 provides a complete guide to new product launches in Turkish bakery and cereals market since January 2010,This report includes detailed data on products including Package...
Related articles
UK: Kellogg dismisses Which? sugar claims
Kellogg has hit back at claims by UK consumer watchdog Which? that some of its cereals contain too much sugar.
UK: Weetabix to "upgrade" UK, North America facilities
Cereal manufacturer Weetabix is to invest GBP20m (US$31.4m) on the upgrade of its facilities in the UK and North America.
UK: Weetabix adds to product range
UK cereal manufacturer Weetabix has announced four new products will be released at the end of the month.
There are currently no comments on this article
Be the first to comment on this article